1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) (RFA-AT-25-003) is sponsored by National Center for Complementary and Integrative Health (NCCIH), NIH HEAL Initiative. This program supports basic and mechanistic pain research from R15-eligible undergraduate-focused serving institutions, health professional schools, or graduate schools.
It promotes integrated, interdisciplinary research partnerships and aims to enhance the pain research environment at the R15-eligible institution.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: R15-eligible undergraduate-focused serving institutions, health professional schools, or graduate schools. Aims to promote integrated, interdisciplinary research partnerships between Principal Investigators (PIs) from R15-eligible institutions and investigators from U.S. domestic institutions, and enhance the pain research environment at the R15-eligible institution for health professional students, undergraduate, and/or graduate students. Confirm the full requirements in the official notice before applying.
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) (RFA-AT-25-003) is funded by National Center for Complementary and Integrative Health (NCCIH), NIH HEAL Initiative. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read article